VIVUS Announces Date of Second Quarter 2014 Update and Financial Results Conference Call
31 juil. 2014 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results for the second quarter ended June 30, 2014 after the NASDAQ...
VIVUS Announces Date of First Quarter 2014 Update and Financial Results Conference Call
29 avr. 2014 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2014 after the NASDAQ...
VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results
24 févr. 2014 16h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV...
VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and Conference Call
19 févr. 2014 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the fourth quarter and year ended December 31, 2013 after...
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil)
21 janv. 2014 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif. and CHESTERBROOK, Pa., Jan. 21, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) and Auxilium Pharmaceuticals, Inc. (Nasdaq:AUXL) today announced that the U.S. Food and Drug...
VIVUS Collaborates With Aetna to Test First Comprehensive Weight Management Program Integrating Weight Loss Medication
14 janv. 2014 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Jan. 14, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), today announced that it has joined with Aetna (NYSE:AET), one of the nation's leading diversified health care...
VIVUS to Present at Upcoming Investor Conference
13 janv. 2014 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment...
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
12 déc. 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Dec. 12, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it has entered into a License and Commercialization Agreement with Sanofi to commercialize...
VIVUS to Present at Upcoming Investor Conference
02 déc. 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Dec. 2, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment...
VIVUS Announces Support for New Obesity Treatment Guidance Urging Active Involvement From Healthcare Providers
21 nov. 2013 07h30 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., Nov. 21, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), today announced its support of new clinical practice guidelines urging healthcare providers to take an active role...